Italy-based Enthera Pharmaceuticals Srl has appointed Aled Williams as chief executive to help it advance treatments for autoimmune conditions. He joins from Polyneuron Pharmaceuticals AG where he was chief business officer. Prior to this, he was chief commercial officer at VectivBio AG, a developer of drugs for rare diseases, and head of commercial operations at Therachon AG which was acquired by Pfizer Inc in 2019.
Enthera announced the appointment on 4 May 2022.
Copyright 2022 Evernow Publishing Ltd